FISCHER vs INDSWFTLTD: Stock Comparison

Fischer Medical Ventures Limited vs Ind-Swift Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Fischer Medical Ventures Limited shows a higher dividend yield and faster revenue growth, while Ind-Swift Limited shows a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Fischer Medical Ventures Limited and Ind-Swift Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FISCHER is more favourable on 4 of 9 scored metrics and INDSWFTLTD on 4These counts are context-free and are not an overall rating.

Key Differences

EPS
FISCHER has higher earnings per share
₹0.45 vs ₹0
Dividend Yield
FISCHER has a higher dividend yield
0.01% vs 0%
Revenue Growth (TTM YoY)
FISCHER has faster revenue growth
98.7% vs 0%
Qtr Sales Growth
FISCHER has stronger quarterly sales growth
98.8% vs 0%
Qtr Profit Growth
INDSWFTLTD has stronger quarterly profit growth
0% vs -642%
ROCE
INDSWFTLTD has a higher ROCE
13.4% vs 11.4%
Net Margin
INDSWFTLTD has a higher net margin
55.01% vs 6.79%
Operating Margin
INDSWFTLTD has a higher operating margin
63.48% vs 14%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFISCHERINDSWFTLTD
SectorHealthcareHealthcare
IndustryMedical Equipment & SuppliesPharmaceuticals

Price

MetricFISCHERINDSWFTLTD
Live Price₹37.94₹15.76
Day Change-2.79%6.13%
Volume21.83 L6.45 L
52-Week High₹1,194.4₹17.82
52-Week Low₹31.05₹14.71
Distance from 52W High-96.82%-11.56%

Valuation

MetricFISCHERINDSWFTLTD
Market Cap₹2,486 Cr₹0 Cr
P/E Ratio80.98x
P/B Ratio6.48x
EPS₹0.45₹0
Book Value₹5.96₹-122
Dividend Yield0.01%0%

Growth

MetricFISCHERINDSWFTLTD
Revenue Growth (TTM YoY)98.7%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth98.8%0%
Qtr Profit Growth-642%0%

Profitability & Leverage

MetricFISCHERINDSWFTLTD
ROE8.59%
ROCE11.4%13.4%
Net Margin6.79%55.01%
Operating Margin14%63.48%
Debt to Equity0.28x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricFISCHERINDSWFTLTD
Promoter Holding11.46% 0.82 pp55.58%
FII Holding4.97% 0.12 pp0%
DII Holding1.38% 0.02 pp0%
Public Holding31.5% 0.49 pp44.42%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fischer Medical Ventures Limited and Ind-Swift Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.